AFT.NZ

AFT Pharmaceuticals Limited

HealthcareDrug Manufacturers - Specialty & GenericNZNZDPeers →via fmp_bulkCountry macro →

$3.91

Jun 05, 2026

AI Brief

Market cap

$410.03M

52w range

—

P / E

—

EPS · FY 2026

$0.14

Volume

—

Revenue · FY 2026

$254.71M

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on AFT Pharmaceuticals Limited’s valuation

Business description

· company · SEC profile

AFT Pharmaceuticals Limited

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Founded

—

IPO

Dec 21, 2015

Employees

110

Auckland

CEO

Hartley Atkinson

CFO

—

Exchange

NZE

Fiscal year

—

Identifiers

· company_identifiers

CIK

CUSIP—

ISINNZAFTE0001S4

FIGI—

LEI—